Paolo Bonvini Selected Research

Paolo Bonvini Research Topics

Disease

19	Neoplasms (Cancer) 01/2022 - 08/2002
8	Rhabdomyosarcoma 01/2022 - 09/2006
4	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2015 - 03/2002
3	Sarcoma (Soft Tissue Sarcoma) 01/2022 - 11/2020
2	Circulating Neoplastic Cells 01/2022 - 01/2021
2	Alveolar Rhabdomyosarcoma 01/2022 - 01/2021
2	Disease Progression 01/2021 - 11/2020
2	Hematologic Neoplasms (Hematological Malignancy) 01/2018 - 08/2002
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2018 - 04/2017
2	Lymphoma (Lymphomas) 05/2013 - 03/2002
1	Renal Cell Carcinoma (Grawitz Tumor) 10/2020
1	Kidney Neoplasms (Kidney Cancer) 10/2020
1	Residual Neoplasm 01/2018
1	Leukemia 04/2017
1	B-Cell Lymphoma (Lymphoma, B Cell) 05/2013
1	Carcinogenesis 10/2011
1	Embryonal Rhabdomyosarcoma 09/2006
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 08/2002
1	Myeloid Leukemia (Leukemia, Myelocytic) 08/2002

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 01/2021 - 03/2002
6	Anaplastic Lymphoma KinaseIBA 01/2016 - 03/2002
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2020
3	AutoantibodiesIBA 01/2022 - 02/2020
3	Phosphotransferases (Kinase)IBA 01/2018 - 07/2009
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 07/2009 - 03/2002
2	Epithelial Cell Adhesion MoleculeIBA 04/2021 - 11/2020
2	Tyrosine (L-Tyrosine)FDA Link 01/2018 - 03/2002
2	NucleophosminIBA 05/2013 - 03/2002
2	Protein Kinases (Protein Kinase)IBA 12/2011 - 04/2006
2	Casein Kinase II (Casein Kinase 2)IBA 12/2011 - 04/2006
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 10/2011 - 05/2004
2	Pharmaceutical PreparationsIBA 10/2011 - 07/2009
2	beta CateninIBA 09/2006 - 08/2002
1	Fibroblast Growth Factor 8IBA 01/2022
1	Cell-Free Nucleic AcidsIBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2021
1	AntigensIBA 01/2021
1	Gamma-protocadherinsIBA 01/2021
1	Tumor Biomarkers (Tumor Markers)IBA 01/2021
1	AutoantigensIBA 01/2021
1	Glycoproteins (Glycoprotein)IBA 11/2020
1	Sunitinib (Sutent)FDA Link 10/2020
1	Insulin-Like Growth Factor Binding Protein 2IBA 02/2020
1	MicroRNAs (MicroRNA)IBA 01/2020
1	Metalloproteases (Metalloproteinases)IBA 01/2020
1	Small Untranslated RNAIBA 01/2020
1	TropomyosinIBA 01/2018
1	entrectinibIBA 01/2018
1	Small Interfering RNA (siRNA)IBA 04/2017
1	Messenger RNA (mRNA)IBA 04/2017
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2016
1	CrizotinibIBA 01/2015
1	Tyrosine Kinase InhibitorsIBA 01/2015
1	tyrosine receptor (receptor, tyrosine)IBA 01/2015
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 05/2013
1	Complementary DNA (cDNA)IBA 05/2013
1	ClathrinIBA 05/2013
1	Bortezomib (Velcade)FDA Link 06/2012
1	UbiquitinIBA 06/2012
1	Proteasome Endopeptidase Complex (Proteasome)IBA 06/2012
1	17- (dimethylaminoethylamino)- 17- demethoxygeldanamycinIBA 06/2012
1	Proteasome InhibitorsIBA 06/2012
1	Cytotoxins (Cytolysins)IBA 10/2011
1	alvocidib (flavopiridol)IBA 07/2009
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 07/2009
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 07/2009
1	Histones (Histone)IBA 09/2006
1	gamma Catenin (Plakoglobin)IBA 09/2006

Therapy/Procedure

7	Therapeutics 01/2022 - 01/2015
2	Drug Therapy (Chemotherapy) 10/2011 - 07/2009